跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
黃 芝瑋
研究員
,
醫學科技學院
https://orcid.org/0000-0002-2551-6199
電子郵件
gracehuang
tmu.edu
tw
h-index
778
引文
17
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2014
2026
每年研究成果
概覽
指紋
網路
專案
(11)
研究成果
(66)
資料集
(1)
類似的個人檔案
(8)
指紋
查看啟用 Chih-Wei Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cancer Risk
83%
Malignant Neoplasm
68%
Electronic Health Record
55%
Odds Ratio
52%
Proton-Pump Inhibitor
50%
Empathy
50%
Chronic Kidney Disease
50%
Case-Control Study
42%
Logistic Regression Analysis
41%
Clinical Research
39%
Patient Care
36%
Computerized Physician Order Entry
35%
Randomized Controlled Trial
35%
Physician
33%
Female Genital Tract Cancer
33%
COVID-19
33%
Cardiovascular Disease
30%
Breast Cancer
27%
Comorbidity
27%
Health Care
22%
Maturity Onset Diabetes of the Young
22%
Antidiabetic Agent
22%
Cervical Cancer
22%
Medicine
21%
Stomach Cancer
19%
Drug Use
19%
Patient Satisfaction
19%
Nephropathy
19%
Drug Therapy
18%
Ovarian Cancer
18%
Hepatocellular Carcinoma
16%
Patient Safety
16%
Cohort Analysis
16%
Meta-Analysis
16%
Disease Association
16%
Arteriovenous Fistula
16%
Renin Angiotensin Aldosterone System
16%
Hemodialysis
16%
Critical Appraisal
16%
Maturation
16%
Benzodiazepine
16%
Community-Acquired Pneumonia
16%
Gene Expression Profiling
16%
Gout
16%
Blood Pressure
16%
Internal Medicine
16%
Dermatosis
16%
Checklist
16%
Occupation (Patient Social Context)
16%
Selective Serotonin Reuptake Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Clinical Research
53%
Chronic Kidney Failure
52%
Proton Pump Inhibitor
50%
Case-Control Study
50%
Breast Cancer
47%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
47%
Cohort Study
45%
Statin (Protein)
41%
Benzodiazepine
38%
Traditional Chinese Medicine
33%
Angiotensin
33%
Female Genital Tract Cancer
33%
Comorbidity
33%
Intubation
29%
Infection
29%
Observational Study
28%
Disease
28%
Comorbidity
26%
Uterine Cervix Cancer
25%
Cancer Registry
23%
Parkinson's Disease
22%
Kidney Disease
22%
Stomach Cancer
21%
Lung Cancer
19%
Angiotensin Receptor Antagonist
19%
Acetylsalicylic Acid
19%
Metformin
19%
Ovary Cancer
18%
Endometrium Cancer
17%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Liver Cell Carcinoma
16%
Low Density Lipoprotein
16%
Major Adverse Cardiac Event
16%
Gout
16%
Thorax Pain
16%
Community Acquired Pneumonia
16%
Omega 6 Fatty Acid
16%
High Density Lipoprotein
16%
Lipoprotein
16%
Health Status
16%
Aldosterone
16%
Hemodialysis
16%
Arteriovenous Fistula
16%
Epidermal Growth Factor Receptor
16%
Vaccination Policy
16%
Renin
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Cardiovascular Disease
16%
Antidiabetic Agent
16%
Nursing and Health Professions
Electronic Health Record
42%
Odds Ratio
34%
Confidence Interval
34%
Hemodialysis
33%
Chronic Kidney Failure
33%
Pilot Study
33%
Health Literacy
33%
Robotics
30%
Patient Care
29%
Comorbidity
21%
Receiver Operating Characteristic
21%
Breast Cancer
20%
Artificial Intelligence
19%
Cohort Analysis
19%
Malignant Neoplasm
19%
Meta Analysis
16%
Physician
16%
Non Melanoma Skin Cancer
16%
Public Health Informatics
16%
Statin (Protein)
16%
Liver Cell Carcinoma
16%
Health Care Delivery
16%
Empathy
16%
Healthcare System
16%
Hospital
16%
Case-Control Study
16%
Drug Use
16%
Gout
16%
Pressure Injury
16%
Hospital Service
16%
Image Subtraction
16%
Arteriovenous Fistula
16%
Bibliometrics
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Alanine Aminotransferase
16%
COVID-19
16%
Education
16%
Glucometer
16%
Elderly Patient
16%
Medication Compliance
16%
Area under the Curve
16%
Infection
14%
Drug Therapy
14%
Cardiovascular Disease
13%
Estimated Glomerular Filtration Rate
12%
Chi Square Test
11%
Intubation
10%
Disease
9%
Sensitivity and Specificity
9%
Health Care Personnel
9%
